Juvenile Arthritis: Meeting the Benchmark with Health Technology

By Thanusha Pillay

July 17, 2024

Introduction

Juvenile idiopathic arthritis (JIA) care has long faced challenges in meeting best practice benchmarks. Despite advancements in molecular medicine and legislative changes to boost paediatric research, many children with JIA still receive suboptimal care. A paper recently published in Current Rheumatology Reports explores how digital health technologies can improve access to treatment, offering a more integrated and efficient approach to JIA management.

The Benchmark Today

As recommended by various global disease authorities, including the British Society for Paediatric and Adolescent Rheumatology and the American College of Rheumatology, the current benchmark for managing JIA emphasises early referral to specialists in paediatric rheumatic diseases for prompt diagnosis and treatment initiation. Treatment should be frequently assessed and adjusted to achieve inactive disease and no pain. To achieve the best health outcomes, long-term management by a diverse interdisciplinary team is essential.

Specialised Paediatric Rheumatology (PR) Centres, usually located in tertiary children’s hospitals in major cities, provide comprehensive support and treatments tailored to both rheumatological and paediatric needs. These centres offer a holistic approach, addressing the unique differences between adult and paediatric care. For instance, physiotherapists guide physical education and home programs, nurses offer strategies and medication advice, podiatrists monitor foot health and development, and ophthalmologists screen eye health in young children. An interdisciplinary care model is key to effective management.

Global Challenges in Managing Juvenile Idiopathic Arthritis

Globally, PR services struggle to meet the current standards of care relative to the projected demand, with a global PR workforce shortage of 88%. A significant factor is the shortage of paediatric rheumatologists, which leads to delayed diagnoses and treatment. For instance, a study of 130 PR centres across 49 countries found that diagnostic delays were more pronounced in low GDP countries. Africa and Asia are the hardest hit – Africa has only 10 PR centres across 54 countries, and China has only 50 centres across over 1.4 billion people. The short supply of PR healthcare providers causes delays in adequate treatment, worsening disease, and poor patient outcomes. Moreover, general practitioners and emergency room physicians often overlook joint swelling and restriction, further hindering timely referrals to specialists.

The Role of Digital Health Technologies

Digital health technologies offer a promising solution to these challenges. Mobile devices like smartphones, tablets, and smartwatches can monitor and assess important health indicators in real-time. For example, electronic pain diaries have been shown to reduce recall bias, while quality of life questionnaires assessed through apps can help gauge disease activity. These tools not only improve efficiency during consultations but also promote psychosocial conversations between patients and healthcare providers.

Telehealth and Remote Monitoring

The COVID-19 pandemic has accelerated the adoption of telehealth in paediatric rheumatology. Although physical examinations are essential, telehealth consultations have proven effective in verifying diagnoses and treatment responses. However, there is room for improvement. Current assessment tools need validation or adaptation for virtual use. For instance, the Video-pGALS (video paediatric Gait Arms Legs Spine) and eVAS (electronic visual analogue scale) are examples of tools that can enhance virtual examinations.

Future Directions and Conclusion

To address the longstanding health disparities in JIA care, it is crucial to integrate digital health technologies into clinical practice. This approach can create an integrative care model involving children, general practitioners, and paediatric rheumatologists. By improving service delivery and interdisciplinary care coordination, we can ensure timely support and better outcomes for children with JIA. Future research should focus on advancing digital health interventions that further reduce health inequalities, especially for those in remote or under-served areas.

Reference url

Recent Posts

lenacapavir HIV prevention
      

Lenacapavir HIV Prevention: Approval and Access Strategy Updates

🌍 *Could a twice-yearly shot revolutionize HIV prevention?*
Gilead Sciences has submitted key applications to the EMA for lenacapavir, a groundbreaking HIV-1 capsid inhibitor designed for use as pre-exposure prophylaxis (PrEP). With promising trial results indicating a significant reduction in HIV infections, this innovation could enhance adherence to prevention strategies globally. Discover more about this game-changing development!

#SyenzaNews #globalhealth #healthcareInnovation

Africa health partnership
      

Strengthening Africa Health Partnership

🌍 Can collaboration redefine Africa’s health landscape?

A newly signed Memorandum of Understanding between Africa CDC and Global Health EDCTP3 promises to enhance health research, clinical trials, and pandemic preparedness on the continent. With a focus on training, local manufacturing, and equitable partnerships, this initiative aims to address pressing global health challenges while improving health outcomes across Africa.

Look into the details of this transformative partnership and its implications for the future of healthcare in the region!

#SyenzaNews #globalhealth #HealthcareInnovation

breast cancer Africa
    

Urgent Call for Enhanced Breast Cancer Africa Control Measures

🚨 Are we doing enough to tackle the imminent breast cancer crisis in Africa?

A recent WHO report reveals alarming trends, predicting that 135,000 women could succumb to breast cancer by 2040 unless urgent actions are taken. The report highlights critical gaps in healthcare infrastructure and capacity, emphasizing the need for investment in screening programs and professional training to improve outcomes across the continent.

Review the full article to explore the necessary steps towards reinforcing breast cancer control measures in Africa.

#SyenzaNews #globalhealth #oncology #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.